This is an internet-based activity that should take 1 hour to complete.
To participate in this archived webinar learners should:
Take the pretest
Listen to webinar
Take the post-test
Complete follow-up evaluation survey
Learning Objectives
At the conclusion of this presentation, participants should be able to:
Correctly apply national guidelines for the initiation, interval, and cessation of cervical cancer screening to patients in your clinical practice
Accreditation Information
Physicians:
ACCREDITATION The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
DESIGNATION ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses:
This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hours, including up to 0.75 pharmacology hour. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.
Others:
A certificate of attendance will be issued indicating that this activity is accredited for up to 1.5 hours ofAMA PRA Category 1 CreditTM.
Sponsoring Information
This program is sponsored by the Association of Reproductive Health Professionals. It is being done in conjunction with Planned Parenthood® Federation of America.
Funding Information
This project and webinar is funded through educational grants from QIAGEN, Digene Corporation, GlaxoSmithKline, Graceway Pharmaceuticals, and Merck and Co. Inc.
Disclosure Information
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Target Audience
The intended audiences for this activity are women’s health and primary care providers and educators, including physicians, nurse practitioners, physician assistants, nurse-midwives, and educators in obstetrics/gynecology, family medicine, internal medicine, and related fields.
Advisory Committee Disclosures
Barbara J.B. Clark, MPAS, PA-C (Planner)
Physician Assistant Knox OB/GYN, Ltd
Ms. Clark is a speaker for Ortho Women’s Health and Urology and Wyeth Pharmaceuticals
Don Downing, RPh(Planner)
Clinical Professor University of Washington School of Pharmacy
Dr. Downing has no affiliations to disclose.
Francisco Garcia, MD, MPH(Planner)
Associate Professor Obstetrics & Gynecology, University of Arizona Health Sciences Center University of Arizona
Dr. Garcia has no affiliations to disclose.
Sherri Sheinfeld Gorin, PhD(Planner)
Associate Professor of Health and Social Behavior Columbia University
Dr. Sheinfeld has no affiliations to disclose.
Richard Guido, MD(Planner)
Associate Professor of Obstetrics/Gynecology & Reproductive Health Magee Women's Hospital
Dr. Guido conducted research for Graceway Pharmaceuticals and Tigress Pharmaceuticals; speaker for Merck and Co., Inc.; consultant for GlaxoSmithKline
Julie Hibben, LMSW, CPSI (Planner)
Director of Education and Outreach PlannedParenthood of Greater Iowa
Ms. Hibben has no affiliations to disclose.
Mary Rubin, RNC, PhD, CRNP(Planner)
Nurse Practitioner University of California San Francisco
Dr. Rubin is a speaker for Digene Corporation and Merck and Co., Inc.
Marie Savard, MD(Planner)
Medical Director Cabrini Missionary Sisters and retirement community, Nursing Home and Long-term Care Facility
Dr. Savard is aspeaker for Digene Corporation and GlaxoSmithKline
Anafidelia Tavares , MD(Planner)
Woman’s Health Initiative Coordinator New York City Department of Health and Mental Hygiene
Dr. Tavares has no affiliations to disclose.
Maria Trent, MD(Planner) Johns Hopkins School of Medicine
Dr. Trent is a speaker for Merck and Co., Inc. Medical Forums.
Thomas C. Wright, MD(Planner)
Associate Professor of Pathology Columbia University - College of Physicians 7 Surgeons
Dr. Wright is a consultant for Glaxo Smith Kline, Merck and Co., Inc. and Roche Molecular Systems, Inc.
ARHP Staff/Consultant Disclosures
Vanessa Cullins, MD
Vice President – Medical Affairs Planned Parenthood Federation of America
Dr. Cullins receives grants and research support from Digene Corporation, Graceway Pharmaceuticals, Merck and Co., Inc., and Ortho Women’s Health, Urology Wyeth Pharmaceuticals; consultant for Merck and Co., Inc.; speaker for Ortho Women’s Health and Urology
Katy Quissell, MPH
Project Manager
Nothing to disclose
Diane Shannon, MD, MPH (Medical Writer)
Consultant (Expert Medical Writer)
Nothing to disclose
Wayne Shields
President and CEO
Nothing to disclose
Amy Swann, MA, CAE
Vice President of Operations
Nothing to disclose
Sandy Worthington MSN, CNM, RNC (Reviewer)
Program Director-Nurse Practitioner
Drexel University College of Nursing and Health Professions
By clicking this check box, you acknowledge that you have read above information
Association of Reproductive Health Professionals – East
1901 L Street, NW, Suite 300, Washington, DC 20036
(202) 466-3825 | ARHP@arhp.org
Association of Reproductive Health Professionals – West
1330 Broadway, Suite 1100, Oakland, CA 96412
(202) 466-3825 | ARHP@arhp.org
Looking for medically accurate, up-to-date, evidence-based educational programming for health care providers and materials for patients on all reproductive health topics, including abortion, contraception, HPV, menopause, menstruation, pregnancy, sexuality? Look no further than the Association of Reproductive Health Professionals (ARHP) – the leading source for trusted medical education and information on reproductive and sexual health.
